<DOC>
	<DOCNO>NCT02186119</DOCNO>
	<brief_summary>This safety efficacy study abicipar pegol patient diabetic macular edema .</brief_summary>
	<brief_title>A Study Abicipar Pegol Patients With Diabetic Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Diagnosis diabetes mellitus ( Type 1 2 ) Decreased vision due diabetic macular edema least 1 eye Best correct visual acuity 20/32 20/320 study eye 20/200 good fellow eye Stroke heart attack within past 3 month History vitrectomy , macular surgery , glaucoma surgery study eye Cataract refractive surgery study eye within last 3 month Laser photocoagulation study eye within last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>